Patents by Inventor John Pieracci

John Pieracci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9102709
    Abstract: Methods and kits for regenerating antibody binding resins are provided. In some embodiments the methods include a first step of washing an antibody binding resin with a reducing solution, followed by a second step of washing the antibody binding resin with a chaotropic solution.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: August 11, 2015
    Assignee: Biogen MA Inc.
    Inventors: Asif Ladiwala, John Pieracci
  • Publication number: 20130331554
    Abstract: Disclosed is a method for enhancing or increasing the concentration of biological product in a final mixture, wherein said biological product has one or more selected characteristics, wherein said method comprises: (a) allowing an initial mixture of biological products with and without said selected characteristics to contact a chromatography medium wherein the quantity of biological products in said initial mixture exceeds the binding capacity or the dynamic binding capacity of said chromatography medium; (b) allowing biological product not having said one or more selected characteristics to be separated by said chromatography medium; and (c) recovering a final mixture of biological products from said chromatography medium wherein said final mixture comprises an enhanced or increased concentration of biological product with one or more selected characteristics, compared to the concentration of biological product in said initial mixture.
    Type: Application
    Filed: November 15, 2011
    Publication date: December 12, 2013
    Applicant: BIOGEN IDEC INC.
    Inventors: Asif Ladiwala, John Pieracci
  • Publication number: 20070215534
    Abstract: Provided are methods of separating an immunoreactive compound from at least one immaterial component, using a simulated moving bed (“SMB”) system and a SMB apparatus for use in these methods. Also provided are purified immunoreactive compounds prepared using the SMB methods and apparatus and methods of treatment with the purified immunoreactive compounds.
    Type: Application
    Filed: May 21, 2007
    Publication date: September 20, 2007
    Inventors: Jorg Thommes, Alan Sonnenfeld, John Pieracci, Lynn Conley, Marc Bisschops, Maarten Pennings
  • Patent number: 6852769
    Abstract: An ultrafiltration membrane is modified to exhibit low protein fouling and yet maintains a greater fraction of the original membrane permeability and retention properties after modification. This is achieved by grafting monomer onto the surface of a highly photoactive membrane such as polyethersulfone, via the process of dipping the polymeric membrane into a solution containing one or more monomers and a chain transfer agent, removing the membrane from the solution, securing the membrane inside of a quartz vessel contained within another vessel of liquid filter, and irradiating the membrane with a UV light at a wavelength between the range of 280 nm and 300 nm. High density grafting and shorter grafted monomer chain length result in low protein fouling and retention of permeability.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: February 8, 2005
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Georges Belfort, James V. Crivello, John Pieracci
  • Publication number: 20030209487
    Abstract: An ultrafiltration membrane is modified to exhibit low protein fouling and yet maintains a greater fraction of the original membrane permeability and retention properties after modification. This is achieved by grafting monomer onto the surface of a highly photoactive membrane such as polyethersulfone, via the process of dipping the polymeric membrane into a solution containing one or more monomers and a chain transfer agent, removing the membrane from the solution, securing the membrane inside of a quartz vessel contained within another vessel of liquid filter, and irradiating the membrane with a UV light at a wavelength between the range of 280 nm and 300 nm. High density grafting and shorter grafted monomer chain length result in low protein fouling and retention of permeability.
    Type: Application
    Filed: April 1, 2003
    Publication date: November 13, 2003
    Inventors: Georges Belfort, James V Crivello, John Pieracci